While TGFβ has been shown to act as a potent tumor suppressor in normal epithelial cells, it also acts as a pro-metastatic factor late in tumor progression, a finding that has been attributed, in part, to its ability to stimulate EMT and the CSC phenotype47,48. Here, TGFB1 is linked to neoplasm.